Akttyva Therapeutics, Inc. received a $255,487 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering (47.041) federal grant program. The award period runs from December 1, 2021 through November 30, 2022 to support SBIR Phase I research titled "AI-Assisted Identification of Small Molecules for Targeted Repair of Vascular Barrier Dysfunctions." The funding will allow Akttyva Therapeutics to utilize artificial intelligence techniques to identify small molecule compounds that can selectively repair dysfunctional vascular barriers, with the goal of developing new targeted therapies. The work is aligned with the NSF Engineering program's goals of fostering innovation in engineering research.